Prostate Cancer News

Panel Advises Against Prostate Cancer ScreeningNo major medical group recommends routine PSA blood tests to check men for prostate cancer, and now a government panel is saying they do more harm than good.
FDA To Decide By April 26 On New Xgeva ApplicationAmgen today announced the FDA plans to decide by April 26 on its application to expand the use of its bone treatment drug Xgeva to prevent or delay the spread of advanced prostate cancer.